Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient focused benefit risk assessment�� why when how should epidemiologists get
… Hilary Smith Pharmacoepidemiology and Risk Management Barcelona, Spain MSPH, Public Health London … Manager in the Pharmacoepidemiology and Risk Management group with RTI-HS. Ms. Smith has over 10 … and research experience, Ms. Smith has worked on projects focused on the prevention of non-communicable diseases in …
Psychometric Evaluation Our psychometricians have extensive experience conducting quantitative evaluations of COAs, evaluating their structure and demonstrating their reliability, validity, and responsiveness, as well as facilitating the interpretation of …
… vaccination rates provide an acceptable value? Cost and Benefit Analysis Researchers with GSK and RTI Health … adults may therefore be economically justifiable. Cost-benefit analysis of vaccination against four preventable …
… Observational Study of Patient-Reported Quality of Life Utilizing a Novel Mobile … OPPORTUNITY Our client wanted to understand the patient journey and assess patient-reported outcomes of women using their treatment for …
… Access and Outcomes Strategy Pharmacoepidemiology and Risk Management Biostatistics Real-World Evidence Patient-Centered Outcomes Assessment Surveys and Observational Studies Staff Members …
… utilization studies Epidemiology of disease Measurement of patient preferences for treatment options Outcomes research …
… of illness studies Literature reviews Measurement of patient preferences for treatment options Patient-reported outcomes (PRO) studies Stated-choice studies …
… and supplementary data (e.g., natural history studies and patient registries) when evaluating the safety and efficacy of drugs for rare …
… Elena Rivero Pharmacoepidemiology and Risk Management Gastroenterology Women's Health Dermatology … led studies aimed at defining burden of disease, disease risk factors, and safety; supported sections of regulatory … epidemiology activities to prepare regulatory documents on benefit-risk review for various marketed products, including …
… Mansfield, Senior Economist and Head, Health Preference Assessment, will participate as a speaker in the DIA 2022 session, Fit-for-Purpose Patient Preference Studies: Emerging Recommendations from IMI … by those involved in preference research, including how decision-makers and patient research partners were …